CN Patent
CN102319224B — 复方甲氧那明的速释-缓释渗透泵制剂
Assigned to SAILE MEDICAL TECHNOLOGY (SHANGHAI) CO LTD · Expires 2013-03-20 · 13y expired
What this patent protects
本发明公开一类含有药物成分为甲氧那明或其盐酸盐、那可丁、氨茶碱、马来酸氯苯那敏的速释-缓释渗透泵片剂,其特征在于该制剂包含两个释药部分,一部分为速释部分,含有1-70%的有效成分,包裹于渗透泵片剂表面,使得药物在进入胃部可快速释放;另一部分为缓释部分,含有30-99%的有效成分,包含于渗透泵片剂内部,控制药物的持续释放可达8小时至24小时。
USPTO Abstract
本发明公开一类含有药物成分为甲氧那明或其盐酸盐、那可丁、氨茶碱、马来酸氯苯那敏的速释-缓释渗透泵片剂,其特征在于该制剂包含两个释药部分,一部分为速释部分,含有1-70%的有效成分,包裹于渗透泵片剂表面,使得药物在进入胃部可快速释放;另一部分为缓释部分,含有30-99%的有效成分,包含于渗透泵片剂内部,控制药物的持续释放可达8小时至24小时。
Drugs covered by this patent
- Balversa (ERDAFITINIB) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.